Ticker
ANIPCompany Name
ANI PHARMACEUTICALS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 139.14M | 18.62% | $ 747.4M |
3/31/2025 | $ 80.74M | 11.98% | $ 674.07M |
12/31/2024 | $ 64.02M | 10.42% | $ 614.38M |
9/30/2024 | $ 92.9M | 16.72% | $ 555.46M |
6/30/2024 | $ 112.59M | 20.89% | $ 538.95M |
3/31/2024 | $ 115.8M | 22.38% | $ 517.46M |
12/31/2023 | $ 118.96M | 24.44% | $ 486.82M |
9/30/2023 | $ 69.82M | 15.54% | $ 449.39M |
6/30/2023 | $ 41.27M | 10.28% | $ 401.39M |
3/31/2023 | $ 9.16M | 2.55% | $ 358.69M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for ANI PHARMACEUTICALS INC is calculated as follows: CF - Operations [ $ 25.78M ] / Revenues [ $ 199.19M ]
(=) OCF % [ 12.94% ]
Minimum
Jun 30, 2022
Maximum
Dec 31, 2023
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 77.08% |
average | 14.31% |
median | 12.65% |
std | 21.12% |